Patents matching “induction”

WO 2025169901

CONJUGUÉ ANTICORPS-MÉDICAMENT CONTENANT UN COMPOSÉ HÉTÉROCYCLIQUE PRÉSENTANT UNE ACTIVITÉ D'INDUCTION DE LA DÉCOMPOSITION DE PROTÉINES MUTANTES KRAS

ASTELLAS PHARMA INC [JP] · Granted Aug 14, 2025 · Expires Aug 9, 2045

US 12310986

Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxidative stress

The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

WO 2025058008

CONJUGUÉ ANTICORPS-MÉDICAMENT CONTENANT UN COMPOSÉ HÉTÉROCYCLIQUE AYANT POUR ACTIVITÉ L'INDUCTION DE LA DÉCOMPOSITION DE LA PROTÉINE KRAS MUTANTE G12D

ASTELLAS PHARMA INC [JP] · Granted Mar 20, 2025 · Expires Mar 15, 2045

US 11873319

Cyclic di-nucleotide induction of type I interferon

The Regents of the University of California · Granted Jan 16, 2024 · Expires Jan 11, 2044

US 11781110

Induction of corneal endothelial cells

The Regents of the University of California · Granted Oct 10, 2023 · Expires Oct 5, 2043

US 11083801

Factor VIII mutation repair and tolerance induction

The United States Government Represented by the Departrment of Veteran Affairs · Granted Aug 10, 2021 · Expires Aug 5, 2041

US 11065330

Induction of antigen-specific tolerance by peripheral phagocytosis

PLS-Design GmbH · Granted Jul 20, 2021 · Expires Jul 15, 2041

US 10980841

Methods and compositions for in vivo induction of pancreatic beta cell formation

The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

US 10975355

Controlled induction of human pancreatic progenitors produces functional beta-like cells

The Regents of the University of California · Granted Apr 13, 2021 · Expires Apr 8, 2041

US 10369208

Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2019 · Expires Aug 1, 2039

US 10293002

Methods and compositions for in vivo induction of pancreatic beta cell formation

The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

US 10272163

Factor VIII mutation repair and tolerance induction

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Apr 30, 2019 · Expires Apr 25, 2039

US 10155014

Cyclic di-AMP induction of type I interferon

The Regents of the University of California · Granted Dec 18, 2018 · Expires Dec 13, 2038

US 9839684

Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

BIOVAXIM LIMITED · Granted Dec 12, 2017 · Expires Dec 7, 2037

US 9827290

Compositions and methods relating to induction of intestinal stem cell homeogenesis and/or regeneration

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 28, 2017 · Expires Nov 23, 2037

US 9763987

Cyclic di-AMP induction of type I interferon

The Regents of the University of California · Granted Sep 19, 2017 · Expires Sep 14, 2037

US 9649344

Methods and compositions for in vivo induction of pancreatic beta cell formation

The Board of Regents of the University of Texas System · Granted May 16, 2017 · Expires May 11, 2037

US 9562070

Induction of tumor immunity by variants of folate binding protein

The Board of Regents of the University of Texas System · Granted Feb 7, 2017 · Expires Feb 2, 2037

US 9526777

Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 27, 2016 · Expires Dec 22, 2036

US 9526737

Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling

The Regents of the University of California · Granted Dec 27, 2016 · Expires Dec 22, 2036

US 9457052

Allograft tolerance induction

United States of America as represented by the Secretary of the Air Force · Granted Oct 4, 2016 · Expires Sep 29, 2036

US 9388221

Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 12, 2016 · Expires Jul 7, 2036

US 9266928

Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2016 · Expires Feb 18, 2036

US 9193739

Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 24, 2015 · Expires Nov 19, 2035